Position in PROK
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,580,000
-$900,000 QoQ
Shares Held
2,000,000
0.0% QoQ
Ownership
0.662%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PROK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bleichroeder LP holds $102,072,643 across 18 Biotechnology names. PROK ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CUE |
Cue Biopharma, Inc.
|
6,819,164 | $47,052,231 | |
| 2 | ERNA |
Ernexa Therapeutics Inc.
|
2,000,000 | $10,000,000 | |
| 3 | DTIL |
Precision Biosciences Inc
|
1,662,500 | $9,143,750 | |
| 4 | IMMX |
Immix Biopharma, Inc.
|
1,000,000 | $9,110,000 | |
| 5 | EYPT |
EyePoint, Inc.
|
316,515 | $4,079,878 | |
| 6 | PROK |
Prokidney Corp.
This page
|
2,000,000 | $3,580,000 | |
| 7 | IRD |
Opus Genetics, Inc.
|
736,842 | $3,352,631 | |
| 8 | GNLX |
GENELUX Corp
|
1,380,666 | $3,341,211 |
All Filings in PROK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,580,000 | 2,000,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,480,000 | 2,000,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,840,000 | 2,000,000 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||